One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

were randomized to DDDR with the algorithm on (treatment) or off (control), and were followed for 6 months. Results. Baseline characteristics and antiarrhythmic drugs used were similar in both groups.

As counterfeit Ozempic circulates in the US, the Food and Drug Administration has issued a warning to Americans. In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

Generic drug manufacturers have had to contend with increasing competition and tight profit margins in recent years. Slapping extra costs through tariffs could undermine their ability to do ...

For any protein with a known three- dimensional shape, the algorithm generates the blueprints for potential drug molecules that increase or inhibit the activity of the protein. Chemists can then ...

Antiarrhythmic drugs (AADs) are often used after ablation for atrial fibrillation (AF); the drugs employed vary, but most common are the drugs that were unsuccessful prior to ablation since it ...

Coast Guard law enforcement officers detained 34 suspected drug traffickers over 11 interdictions. More than 24 tons of illegal narcotics worth about $510 million was seized by the US Coast Guard ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.